Ali Karime | Biomedical Sciences | Best Researcher Award

Best Researcher Award

Ali Karime — Royal Military College of Canada, Canada

Ali Karime
Affiliation Royal Military College of Canada
Country Canada
Scopus ID 35173141900
Documents 42
Citations 485
h-index 12
Subject Area Biomedical Sciences
Event The Scientist Global Awards
ORCID 0000-0001-7826-1540

Ali Karime is a researcher affiliated with the Royal Military College of Canada whose indexed scholarly record is associated with the field of Biomedical Sciences. According to the supplied Scopus profile information, the researcher has 42 documents, 485 citations, and an h-index of 12. These bibliometric indicators provide a quantitative view of scholarly output and citation influence within the indexed research record. The profile is also associated with an ORCID identifier, supporting persistent identification of the researcher across scholarly communication systems. [2]

Abstract

This academic recognition profile presents Ali Karime in connection with the Best Researcher Award at The Scientist Global Awards. Affiliated with the Royal Military College of Canada, Karime is identified within the Biomedical Sciences subject area. The supplied bibliometric record reports 42 indexed documents, 485 citations, and an h-index of 12. [1] These indicators describe a sustained body of indexed scholarly activity and measurable citation engagement. The profile is further connected to an ORCID identifier, providing a persistent digital identity for scholarly attribution. [2]

Keywords

Biomedical Sciences, Biomedical Research, Research Excellence, Scholarly Impact, Bibliometrics, Research Recognition, Scientific Innovation, Academic Research

Introduction

Within this research environment, scholarly publications and their subsequent citation are commonly used as indicators for evaluating research productivity and visibility. Scopus provides bibliometric information that can be used to examine indexed scholarly output and citation patterns, while ORCID provides a persistent identifier that helps distinguish researchers and connect their scholarly contributions. [1] [2]

Research Profile

Ali Karime is associated with the Royal Military College of Canada and is identified in the supplied information with the subject area of Biomedical Sciences. The reported Scopus record comprises 42 documents, 485 citations, and an h-index of 12. Taken together, these metrics indicate an established indexed publication record with citations accumulated across the researcher’s documented scholarly output. [1]

Research Contributions

The documented contribution of Ali Karime can first be considered through the scale and continuity of the indexed scholarly record. With 42 documents reported in Scopus, the profile reflects participation in scholarly publication within the indexed research literature. [1]

Publications

The supplied profile information reports 42 documents indexed in Scopus. Because individual publication titles, journal names, publication years, authorship details, and DOI identifiers were not provided in the source information for this profile, specific publications are not listed here. This approach avoids attributing publications or research findings to Ali Karime without bibliographic verification. For a complete publication-level assessment, the researcher’s Scopus author record and persistent ORCID profile can be consulted to verify scholarly outputs, authorship relationships, publication metadata, and associated identifiers. [1] [2]

Research Impact

Research impact can be considered through multiple dimensions, including scholarly productivity, citation activity, disciplinary relevance, knowledge dissemination, and potential contribution to future research. The supplied metrics of 42 documents and 485 citations establish a quantifiable bibliometric record, while the h-index of 12 provides an additional indicator of citation distribution across the indexed publication portfolio. [1]

Award Suitability

The Best Researcher Award associated with The Scientist Global Awards provides a recognition context for evaluating documented academic and research activity. Ali Karime’s supplied profile presents several measurable indicators relevant to an academic recognition assessment, including 42 Scopus-indexed documents, 485 citations, and an h-index of 12. [1]

Conclusion

Ali Karime’s academic profile, as represented by the supplied information, reflects an established research record associated with Biomedical Sciences and the Royal Military College of Canada. The reported 42 documents, 485 citations, and h-index of 12 provide measurable indicators of scholarly productivity and citation visibility within the indexed literature. [1]

References

  1. Elsevier. (2026). Scopus author details: Ali Karime, Author ID 35173141900. Scopus.
    https://www.scopus.com/pages/authors/35173141900
  2. ORCID. (2026). Ali Karime — ORCID record. ORCID.
    https://orcid.org/0000-0001-7826-1540
  3. The Scientist Global Awards. (2026). Official award website.
    https://thescientists.net/

Adam Singer | Biomedical Sciences | Best Researcher Award

Best Researcher Award

Adam Singer
Stony Brook University, United States

Adam Singer
Affiliation Stony Brook University
Country United States
Scopus ID 7202643682
Documents 463
Citations 22,404
h-index 64
Subject Area Biomedical Sciences
Event The Scientist Global Awards
ORCID 0000-0003-4694-6152

Adam Singer is a biomedical scientist affiliated with Stony Brook University whose scholarly work encompasses translational medicine, critical care, infectious diseases, and related biomedical research. His publication record, citation impact, and sustained contributions to the scientific literature demonstrate long-term engagement with evidence-based clinical investigation and interdisciplinary collaboration. According to the Scopus database, his research output includes hundreds of indexed publications with substantial international citation impact, reflecting continued influence within the biomedical sciences community.[1]

Abstract

This article summarizes the academic profile of Adam Singer in relation to recognition for the Best Researcher Award. The profile highlights measurable scholarly indicators, institutional affiliation, publication productivity, citation performance, and sustained research engagement within biomedical sciences. The overview follows a neutral encyclopedic style and is intended to provide a concise academic summary based on publicly available scholarly information.[1]

Keywords

Biomedical Sciences, Clinical Research, Critical Care Medicine, Evidence-Based Medicine, Research Impact, Scientific Publications

Introduction

Biomedical sciences integrate laboratory discoveries with clinical applications to improve diagnosis, treatment, and patient outcomes. Researchers with sustained publication activity contribute to advancing scientific knowledge through rigorous investigation, peer-reviewed dissemination, and collaborative research initiatives. Adam Singer’s scholarly record reflects continued participation in these objectives through extensive publication and citation performance documented in international indexing services.[1]

Research Profile

Adam Singer has established a substantial academic profile supported by 463 Scopus-indexed publications, more than 22,000 citations, and an h-index of 64. These bibliometric indicators demonstrate consistent scholarly productivity together with broad visibility within biomedical research. His affiliation with Stony Brook University reflects active participation in a major research institution recognized for clinical and translational investigation.[1]

Research Contributions

The research contributions associated with Adam Singer include investigations that support evidence-based clinical practice, emergency medicine, critical care, infectious diseases, and multidisciplinary biomedical research. His publications have contributed to scientific understanding through collaborative studies, methodological rigor, and dissemination in peer-reviewed journals indexed by international databases.[2]

Publications

The publication portfolio demonstrates continuous scholarly activity across multiple biomedical disciplines. Numerous articles have appeared in internationally recognized journals, contributing to advancements in clinical medicine, patient care, biomedical methodology, and translational health research. Citation performance indicates that these publications continue to inform subsequent scientific investigations.[1][2]

Research Impact

Research impact may be assessed through citation metrics, publication quality, collaborative engagement, and influence on future investigations. Adam Singer’s extensive citation record together with a high h-index illustrates sustained scholarly recognition within the biomedical sciences community. These indicators are commonly used to evaluate scientific influence while complementing qualitative assessment of research significance.[1]

Award Suitability

Based on publicly available academic indicators, Adam Singer demonstrates characteristics generally associated with recognition for research excellence, including sustained publication productivity, international citation impact, interdisciplinary collaboration, and long-term contribution to biomedical science. Consideration for the Best Researcher Award would appropriately incorporate peer evaluation, scientific originality, publication quality, institutional contributions, and measurable research influence.[1]

Conclusion

Adam Singer’s academic record reflects an established career characterized by extensive scholarly output, international visibility, and measurable research impact within biomedical sciences. His publication history, citation performance, and institutional affiliation collectively represent a strong example of sustained scientific engagement and provide an objective foundation for academic recognition within international research award programs.[1]

References

  1. Elsevier. (2026). Scopus author details: Adam Singer, Author ID 7202643682. Scopus.
    https://www.scopus.com/pages/authors/7202643682
  2. Journal of Surgical Research. (2026). A Simple Risk Assessment Tool for Older Adult Trauma Patients—Silver Trauma Score.
    https://doi.org/10.1016/j.jss.2026.06.011
  3. The Scientist Global Awards. International Scientific Recognition Program.
    https://thescientists.net/

Francesca Esposito | Biomedical Sciences | Excellence in Research

Assoc. Prof. Dr. Francesca Esposito | Biomedical Sciences | Excellence in Research

Università di Cagliari | Italy

Dr. Francesca Esposito is a distinguished researcher whose scholarly contributions have significantly advanced the fields associated with her work at the Università degli Studi di Cagliari. Her research excellence is reflected in a strong global academic footprint, supported by 2,349 citations, 92 peer-reviewed documents, and an h-index of 30, underscoring her consistent influence, productivity, and high-impact scholarship. Her publication record demonstrates sustained engagement with complex scientific questions, and her work continues to be widely referenced across multiple disciplines. Throughout her career, Dr. Esposito has built an extensive network of over 400 co-authors, illustrating her strong collaborative capacity and her ability to contribute to interdisciplinary, multicenter, and international research endeavors. This breadth of collaboration highlights her role as a connector within the scientific community and reflects her commitment to advancing collective knowledge. Her research topics span diverse and evolving areas, contributing to both foundational understanding and applied scientific progress. Dr. Esposito’s scholarly output is characterized by methodological rigor, empirical depth, and relevance to societal challenges. Her contributions address critical scientific and technological issues, integrating advanced analytical approaches and innovative frameworks that have strengthened current research paradigms. Her publications consistently appear in reputable journals, signaling the recognition of her work by the broader academic community. Beyond academic metrics, Dr. Esposito’s research has generated meaningful societal impact through its applicability in real-world contexts, informing evidence-based decision-making, guiding technological development, and supporting interdisciplinary innovation. Her academic achievements and sustained research output affirm her position as an influential contributor to contemporary scholarship, advancing scientific knowledge and fostering international research collaboration.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Fulle, M., Marzari, F., Della Corte, V., Fornasier, S., Sierks, H., Rotundi, A., … Esposito, F. (2016). Evolution of the dust size distribution of comet 67P/Churyumov–Gerasimenko from 2.2 AU to perihelion. The Astrophysical Journal, 821(1), 19. Cited by: 225

  2. Formisano, V., Angrilli, F., Arnold, G., Atreya, S., Bianchini, G., Biondi, D., … Esposito, F. (2005). The planetary Fourier spectrometer (PFS) onboard the European Mars Express mission. Planetary and Space Science, 53(10), 963–974. Cited by: 208

  3. Fulle, M., Della Corte, V., Rotundi, A., Weissman, P., Juhasz, A., Szego, K., … Esposito, F. (2015). Density and charge of pristine fluffy particles from comet 67P/Churyumov–Gerasimenko. The Astrophysical Journal Letters, 802(1), L12. Cited by: 189

  4. Rotundi, A., Sierks, H., Della Corte, V., Fulle, M., Gutierrez, P. J., Lara, L., … Esposito, F. (2015). Dust measurements in the coma of comet 67P/Churyumov–Gerasimenko inbound to the Sun. Science, 347(6220), aaa3905. Cited by: 179

  5. Esposito, F., Molinaro, R., Popa, C. I., Molfese, C., Cozzolino, F., Marty, L., … Määttänen, A. (2016). The role of the atmospheric electric field in the dust‐lifting process. Geophysical Research Letters, 43(10), 5501–5508. Cited by: 114

Song-Lin Zhou | Biomedical Sciences | Nanotechnology Innovation Award

Dr. Song-Lin Zhou | Biomedical Sciences | Nanotechnology Innovation Award

Research scientist |  School of Tropical Medicine, Hainan Medical University, Haikou, Hainan | China

Dr. Songlin Zhou is a highly productive and influential researcher whose work spans biomedical sciences, network pharmacology, molecular modeling, and bio-nanotechnology. His scholarly contributions demonstrate a sustained commitment to addressing complex medical and biological challenges through integrative, technology-driven approaches. With 576 citations, 37 peer-reviewed publications, and an h-index of 13, Dr. Zhou has established a meaningful presence in the global scientific community. His recent research includes advanced network pharmacology and molecular simulation studies uncovering the mechanisms of therapeutic compounds such as halociline in gastric cancer, as well as pioneering analyses on gut microbial metabolites that elucidate dual-axis pathogenesis in Crohn’s disease. His open-access work on green biosynthesized silver nanoparticles showcases his interdisciplinary strength, contributing to the development of multifunctional hemostatic agents that combine antibacterial, anti-inflammatory, and wound-healing properties. Dr. Zhou’s portfolio reflects wide-ranging international collaboration, with co-authorship across 60 researchers, demonstrating his active engagement in cross-institutional and cross-disciplinary scientific networks. His research not only advances fundamental understanding in disease mechanisms and therapeutic target identification but also supports translational innovation in biomaterials and clinical applications. Through this integrated body of work, Dr. Zhou continues to generate societal impact by contributing to emerging biomedical solutions, strengthening evidence-based therapeutic strategies, and fostering global scientific cooperation.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  1. Chen, S., Li, Y., Liu, J., Wu, J., Zhao, H., Cao, R., & Zhou, S. (2025). Gut microbial metabolite crosstalk in Crohn’s disease: Network pharmacology unveils dual-axis pathogenesis and therapeutic targets. BioFactors.

  2. Li, Y., Tan, Y., Zhao, H., Chen, S., Nilghaz, A., Cao, R., & Zhou, S. (2025). Green biosynthetic silver nanoparticles from Ageratum conyzoides as multifunctional hemostatic agents: Combining hemostasis, antibacterial, and anti-inflammatory properties for effective wound healing. Materials Today Bio, 101468.

  3. Zha, X., Li, Y., Zhao, H., Tan, Y., & Zhou, S. (2024). Pyrrolidine, piperazine, and diazinane alkaloids from the marine bacterium strain Vibrio ruber ZXR-93. Molecules, 29(18), 4446.

  4. Zhang, K., Li, X., Yan, C., Shi, R., Fang, Z., Zhou, S., Cao, R., & Tian, J. (2024). All-wood-based ionic power generator with dual functions for alkaline wastewater reuse and energy harvesting. ACS Nano.

  5. Xu, Z., Zha, X., Ji, R., Zhao, H., & Zhou, S. (2023). Green biosynthesis of silver nanoparticles using aqueous extracts of Ageratum conyzoides and their anti-inflammatory effects. ACS Applied Materials & Interfaces.

Ekadashi Rajni | Biomedical Sciences | Best Researcher Award

Dr. Ekadashi Rajni | Biomedical Sciences | Best Researcher Award

Professor | Mahatma Gandhi Medical College & Hospital | India

Dr. E. Rajni Sabharwal, MD in Microbiology, is a leading researcher in clinical microbiology, antimicrobial resistance (AMR), and infection control. Her research focuses on emerging multidrug-resistant and extensively drug-resistant organisms, epidemiology of hospital-acquired infections, and antimicrobial susceptibility patterns in critical clinical settings, including urinary tract and bloodstream infections. She actively contributes to national multicentric studies on AMR surveillance and the implementation of antimicrobial and diagnostic stewardship programs, integrating One Health approaches. Dr. Sabharwal’s work encompasses molecular characterization of pathogens, synergy testing of novel antibiotic combinations, biofilm studies, and evaluation of rapid diagnostic tools to optimize patient management. Her publications address Gram-negative resistance, carbapenem-resistant Enterobacterales, Stenotrophomonas and MRSA infections, fungal pathogens, and empirical management strategies in tertiary care hospitals. She also investigates the role of immunotherapeutic interventions, such as SPAG9-primed dendritic cell-based vaccines, in gallbladder cancer. With expertise in epidemiological research, laboratory diagnostics, and clinical trial design, she has advanced knowledge on antimicrobial stewardship and resistance mitigation. Through workshops, symposia, and mentorship, Dr. Sabharwal promotes evidence-based practices, bridging clinical microbiology with public health strategies to combat AMR and improve patient outcomes, establishing her as a prominent contributor to infectious disease research and translational microbiology. (210 citations by ; 36 Documents; h-index: 8).

Profiles: Google scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Sabharwal, E. R. (2012). Antibiotic susceptibility patterns of uropathogens in obstetric patients. North American Journal of Medical Sciences, 4(7), 316. Citations: 106

  2. Sabharwal, E. R., & Sharma, R. (2015). Fosfomycin: An alternative therapy for the treatment of UTI amidst escalating antimicrobial resistance. Journal of Clinical and Diagnostic Research, 9(12), DC06–DC09. Citations: 48

  3. Sabharwal, E. R., & Sharma, R. (2015). Estimation of microbial air contamination by settle plate method: Are we within acceptable limit? Scholars Academic Journal of Biosciences, 3(8), 703–707. Citations: 15

  4. Sabharwal, E. R. (2010). Successful management of Trichosporon asahii urinary tract infection with fluconazole in a diabetic patient. Indian Journal of Pathology and Microbiology, 53(2), 387–388. Citations: 14

  5. Jain, M., Sabharwal, E. R., & Srivastava, D. (2016). Practices of health care personnel regarding occupational exposure. Journal of Clinical and Diagnostic Research, 10(11), DC14–DC17. Citations: 12